|
Post by mango on Dec 26, 2022 20:15:07 GMT -5
2023 has so much in store for us. Here’s 5 things to look forward to!
• Phase 4 Afrezza ABC pump-switch clinical trial
• Phase 3 Afrezza India clinical trial for international approval
• Phase 3 Afrezza Pediatrics clinical trial for pediatrics approval
• Phase 1 Receptor Life Sciences with out-licensed MannKind Technosphere Cannabidiol clinical trial
• Phase 2 Fosun Pharma clinical trial with out-licensed MannKind tumor drug
We should also see publications of the Clofazimine Phase 1 clinical trial.
|
|